[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Colchicine 0.5 mg tablets for the first 3 days, twice a day, and then for the next 27 days, once a day. In this group, in addition to colchicine, people will be prescribed drugs listed in the national protocol for the treatment of Covid-19 disease (including famotidine, cetirizine, N-acetylcysteine, bromhexine, naproxen, and fluticasone spray ).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: Patients in this group receive placebo tablets (containing oral calcium chloride, Caspian Pharmaceutical Company, Iran) for the first 3 days, twice a day, and then for the next 27 days, once a day. In addition to placebo, these participants will be prescribed the drugs listed in the National Covid-19 Treatment Protocol (including famotidine, cetirizine, N-acetylcysteine, bromhexine, naproxen, and fluticasone spray ).", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": 310, "treatment_name": "Colchicine", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]